Hemant Vishwakarma THESEOBACKLINK.COM hello@theseobacklink.com
Email Us - hemantx96@gmail.com
directory-link.com | webdirectorylink.com | smartseobacklink.com

Links -> Link Details

Title Astrazaneca’s $6 billion collaboration with Daiichi Sankyo for Commercializing DS-1062.
URL https://mellalta.com/development-marketing-strategy-behind-daiichi-sankyos-ds-1062-6-billion-deal-with-astrazeneca/
Category Fitness Health --> Pharmacy
Meta Keywords Non-Small Cell Lung cancer, Triple negative breast cancer, NCLC, TNBC, AstraZaneca, Daiichi Sankyo, Antibody drrug, DS1062, Oncology pipeline, antibody drug conjugate, ADC, TROP-2
Meta Description Daiichi Sankyo unveiled about the collaboration between them and AstraZeneca for antibody drug conjugate, DS-1062. This news has created absolute havoc in the Pharma market.
Owner Emma Stones
Mellalta Meets LLP is a research-based consultancy with a global footprint. We have worked with firms around the world to help them optimize their business strategy and transform their business decisions